Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Demetri, George D, Prof, Reichardt, Peter, Prof, Kang, Yoon-Koo, Prof, Blay, Jean-Yves, Prof, Rutkowski, Piotr, MD, Gelderblom, Hans, MD, Hohenberger, Peter, Prof, Leahy, Michael, FRCP, von Mehren, Margaret, Prof, Joensuu, Heikki, Prof, Badalamenti, Giuseppe, MD, Blackstein, Martin, FRCP, Le Cesne, Axel, MD, Schöffski, Patrick, Prof, Maki, Robert G, Prof, Bauer, Sebastian, MD, Nguyen, Binh Bui, MD, Xu, Jianming, MD, Nishida, Toshirou, MD, Chung, John, MD, Kappeler, Christian, PhD, Kuss, Iris, MD, Laurent, Dirk, MD, Casali, Paolo G, MD
Published in The Lancet (British edition) (26.01.2013)
Published in The Lancet (British edition) (26.01.2013)
Get full text
Journal Article
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Woll, Penella J, Prof, Reichardt, Peter, MD, Le Cesne, Axel, MD, Bonvalot, Sylvie, MD, Azzarelli, Alberto, MD, Hoekstra, Harald J, Prof, Leahy, Michael, FRCP, Van Coevorden, Frits, MD, Verweij, Jaap, Prof, Hogendoorn, Pancras CW, Prof, Ouali, Monia, MSc, Marreaud, Sandrine, MD, Bramwell, Vivien HC, Prof, Hohenberger, Peter, Prof
Published in The lancet oncology (01.10.2012)
Published in The lancet oncology (01.10.2012)
Get full text
Journal Article